Shire v. Amneal – Compound Claim Not Obvious and API Supplier Not Liable Under FDA Safe Harbor
Patent Licensors Beware – No Challenge Clause Does Not Bar Challenge Before the PTAB
Teaching Away Negated by References Disclosing How to Offset Disadvantages
For BioPharma, Citing Relevant Art During Prosecution Does Not Appear to Minimize IPR Risk
Does the scope of immunity from assertions of patent infringement against U.S. government contractors under 28 U.S.C. § 1498 extend to acts of indirect infringement?
Connect: Email
Subscribe: Subscribe via RSS